Strategic merger Potential cross-sell opportunities with radiopharmacy networks and hospitals through Pharmalogic's merger with Radiopharmacy to offer integrated radionuclide sourcing, distribution, and nuclear medicine services.

Niche radiopharmacy Leverage the specialized radiopharmacy capability to target radiology departments and nuclear medicine programs that require certified isotopes, dosimetry services, and regulatory-compliant supply chains.

Small firm agility As a small team, there may be high responsiveness to partnerships and pilot programs; propose low-friction pilot deals for contract manufacturing, labeling, or niche radiopharmaceuticals to test collaboration potential.

Growth via partnerships Given revenue in the lower range and presence of larger peers in the market, position Pharmalogic as a flexible partner for scale-up collaborations, white-label capabilities, or co-development with mid-market health systems.

Digital readiness WordPress-based digital footprint suggests opportunities to enhance online visibility for radiopharmacy services, certification offerings, and regulatory compliance resources to attract hospital purchasers and procurement managers.